Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bird flu
Research
Tiba wins BARDA contract to develop RNAi flu therapeutics
The $749,999 contract will see Tiba Biotech build on previous work to develop new a RNAi-based therapeutic against the H1N1 strain of the swine flu.
Helen Floersh
Jul 11, 2024 3:35pm
CDC has 1M bird flu tests, but experts see COVID misstep repeats
Jun 20, 2024 1:34pm
Novacyt develops new tests for COVID-19, bird flu
Dec 14, 2020 8:15am
